Cheryl Pegus
CIK 1572448 · last filed 2026-05-21
Cheryl Pegus is a corporate insider who has filed 30 SEC Form 4 insider transactions across 6 companies since 2013. The most recent filing shows the insider bought $100.0K of BSX on May 21, 2026. Across all open-market trades the lifetime net is −$18.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.18M
6
30
-$18.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BSX | Director | 1,770 | $46.06 | $81.5K | $100.0K | 5 | 2026-05-21 |
| CON | Director | 20,740 | $32.69 | $678.0K | $0 | 2 | 2025-11-06 |
| PHR | Director | 15,825 | $10.86 | $171.9K | -$19.03M | 7 | 2022-02-23 |
| TCMD | Director | 9,131 | $27.74 | $253.3K | $27.9K | 9 | 2020-05-06 |
| CGNT | Director | 0 | $8.92 | $0 | $0 | 5 | 2018-04-23 |
| COGENTIX MEDICAL INC /DE/ (VSCI) Delisted | Director | 16,000 | — | — | $0 | 2 | 2014-08-04 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | BSX | Buy (P) | +1,770 | $100.0K | EDGAR |
| 2026-05-11 | BSX | Grant (A) | — | $0 | EDGAR |
| 2026-03-04 | BSX | Grant (A) | — | $0 | EDGAR |
| 2025-11-06 | CON | Grant (A) | +7,748 | $0 | EDGAR |
| 2025-05-09 | BSX | Grant (A) | — | $0 | EDGAR |
| 2024-11-29 | CON | Grant (A) | +12,992 | $0 | EDGAR |
| 2024-06-04 | BSX | Grant (A) | — | $0 | EDGAR |
| 2022-02-23 | PHR | — | — | $0 | EDGAR |
| 2021-07-12 | PHR | Grant (A) | +2,605 | $0 | EDGAR |
| 2021-05-26 | PHR | Tax (F) | −3,555 | -$161.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.